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DOI: 10.1039/c0lc00587hCounting the different subpopulations of cells in a fingerprick of human blood is important for
a number of clinical point-of-care (PoC) applications. It is a challenge to demonstrate the integration of
sample preparation and detection techniques in a single platform. In this paper we demonstrate
a generic microfluidic platform that combines sample processing and characterisation and enumeration
in a single, integrated system. Results of microfluidic 3-part differential leukocyte (granulocyte,
lymphocyte and monocyte) counts, together with erythrocyte and thrombocyte (platelet) counts, in
human blood are shown and corroborated with results from hospital clinical laboratory analysis.1 Introduction
1.1 Point-of-care haematology
Diagnostic testing at or near the site of patient care is often
termed ‘near-patient’ or ‘point-of-care’ (PoC) testing. The
applications of PoC testing are widespread, including the use of
instrument-free, disposable reagent test strips, such as the home
pregnancy kit or blood glucose test, through to portable hand-
held or bench-top devices used, for example, in blood gas
analysis (see Price1 for a review).
In recent years, PoC testing in haematology has increased
significantly. The full blood count (FBC), the most common
clinical indicator of patient health, is one area where PoC systems
are expected to make a significant impact. The FBC includes (at
least) a 3- (or 5-)part leukocyte, or white blood cell (WBC)
differential count, haemoglobin (Hb) concentration, platelet
(PLT) count, red blood cell (RBC) count and a variety of red cell
indices related to red cell size and haemoglobin content.
ICSH guidelines2 have identified a clear need for a PoC FBC
for use in areas including GP surgeries, pharmacies and resi-
dential settings. Such a device needs to be portable, the test must
be minimally invasive and the system simple to use. For self-
testing devices, capillary blood can be collected from a finger
puncture, such as with glucose tests3 or anticoagulation therapy.4
There are some examples of small FBC systems. The simplest
is the HemoCue WBC system,5,6 which requires 10 mL of bloodaPhilips Research Laboratories, 101 Cambridge Science Park, Milton
Road, Cambridge, CB4 0FY, UK
bSchool of Electronics and Computing Science, University of Southampton,
Highfield, Southampton, SO17 1BJ, UK. E-mail: hm@ecs.soton.ac.uk;
Fax: +44(0)2380 593029; Tel: +44(0)2380 593330
cDivision of Infection, Inflammation and Repair, School of Medicine,
University of Southampton, Southampton, SO16 6YD, UK
† Published as part of a LOC themed issue dedicated to UK Research:
Guest Editors Professors Hywel Morgan and Andrew deMello.
This journal is ª The Royal Society of Chemistry 2011and measures total WBC count (no differential). The Chempaq
device uses a disposable cartridge that is filled with 20 mL of
blood. It measures a 3 part differential WBC, RBC and platelet
counts with a single disposable cartridge.7–9 All these devices
have been CE marked (Europe) and 510k approved (US), which
allows their use in the clinical environment by trained profes-
sionals. They are not, however, approved for ‘self-testing’ use by
the patient.
1.2 Sample preparation: microfluidics
A small 2 mL drop of blood contains 10 000 000 erythrocytes and
14 000 leukocytes of which only 600 will be monocytes. To cover
this very large dynamic range, the sample is used with dilution
ratios of 1 : 10 000 or 1 : 20 for erythrocytes and leukocytes,
respectively. To count all the available monocytes within for
example one minute implies flow rates of at least 40 mL min1;
microfluidic technologies offer solutions to handling and pro-
cessing such volumes.10,11 The HemoCue cuvette is one example
of a haematology test that uses a very simple microfluidic
cartridge. In this system, 10 mL of blood is drawn by capillary
forces into a disposable micro-cuvette containing the dried
reagents necessary for erythrocyte lysis and either haemoglobin
labelling or WBC staining.5
The demand for complex multi-parameter analysis of blood
necessitates a different approach to sample preparation. In milli-
fluidic approaches,7,12 such as the Chempaq cartridge, the blood
is mixed in a reservoir after capillary metering of a known
volume of blood. Reagents are stored in the mixing reservoir as
liquids and convective mixing is achieved by a small magnetic
stirrer. Pumping relies on externally delivered gas pressure.
Networks of microfluidic channels can be designed and tuned
to achieve desired mixing and dilution ratios while minimizing
the need for externally driven valves or pumps.13,14 Microfluidic
devices also offer methods for controlled cell lysis, and a device
for rapid and continuous erythrocyte lysis has been reported.15Lab Chip, 2011, 11, 1249–1255 | 1249
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View OnlineThe lysis reagent sheathes a stream of whole blood, lysing the
RBCs. Following lysis, cells are returned to isotonic conditions
by addition of phosphate buffered saline (PBS).Fig. 1 (a) Schematic diagram of the microfluidic impedance sensor, and
the configuration of the detection electronics. The channel is a square
cross section (40 mm  40 mm), and the electrodes are 30 mm wide with
a 40 mm gap. The figure shows the largest common blood cell (monocytes,
16 to 20 mm diameter) and the platelet size (1–3 mm diameter) for
reference. (b) Photographs of the impedance chip, which is 15 mm 
20 mm in size, with two zooms of the sensing region. This consists of two
pairs of overlapping electrodes; signal input is on the top pair (1,2); the
bottom pair (3,4) is connected to a differential virtual ground current
sensing electronics.1.3 Sample detection: impedance cytometry
Cells are usually identified and enumerated using optical (light
scatter) or electrical (Coulter) methods, or a combination of
both. Electrical detection methods readily lend themselves to
miniaturisation. The first cytometer capable of counting and
sizing single particles was developed by Coulter.17 It measures the
DC resistance (or low frequency impedance) change caused by
a cell passing through a narrow orifice separating two electrically
isolated fluid-filled chambers. This principle has been mini-
aturised in the form of a micro-Coulter counter by a number of
authors.18 Microfluidic impedance cytometry (MIC) is an
evolution of the micro-Coulter counter where micro-electrodes
are integrated into the walls of the micro-channel and cell
impedance properties are measured over a range of frequencies.
Recently Holmes et al.19 demonstrated the use of MIC for
identification and enumeration of the three common leukocytes
in human blood. Further developments include the use of an
‘‘impedance label’’ to aid in discriminating sub-populations of
cells, such as CD4+ monocytes in a mixed population.20 For
recent reviews on the technology see Sun and Morgan18 and
Cheung et al.21
The principal distinction between micro-Coulter counters and
MIC is the fact that in the former the electric field is in the same
direction (longitudinal) to the fluid flow and confined by the
diameter and length of the orifice, while in the latter the electric
field is substantially perpendicular to the fluid flow and confined
by the diameter of the channel and the geometry of the elec-
trodes. The two approaches deal in a fundamentally different
way with the unavoidable issue of electrolysis. In micro-Coulter
counters the electrodes tend to be large and well removed from
the orifice to spread bubble formation over a large (electrode)
area and keep the gas products away from the orifice. In contrast,
in MIC the electrodes are small and placed in the high flow region
of the channel itself which means that products of electrolysis are
continuously removed by the flow. This means that MIC can be
easily integrated with the continuous-flow sample preparation
techniques discussed in the previous section. In addition, the
confinement of the electric field means that in MIC it is easy to
incorporate pairs of electrodes, so that differential sensing can be
used to correct for any drift in the electrode–fluid interface, or the
properties of the carrier fluid. Moreover, because the electrodes
are within the channel itself, there are no aperture access resis-
tances and the sensing volume itself is small, leading to an
improvement of thermal noise limit of roughly a factor of 2,
which in turn leads to a larger dynamic range of particles for
a given aperture. The small parasitic capacitances associated with
microelectrode systems also allow measurements to be made at
relatively high frequencies.
In this paper we describe the design and testing of a generic
microfluidic platform technology which combines sample prep-
aration with impedance cytometry in a single, hybrid cartridge.
The system takes a small volume of human blood, provides all
sample preparation and measures a 3-part differential, platelet
and erythrocyte counts and haemoglobin concentration.1250 | Lab Chip, 2011, 11, 1249–12552 Microfluidic impedance cytometry for FBC
The FBC system consists of two parts, the impedance measuring
chip (shown schematically in Fig. 1) and a microfluidic sample
preparation block (Fig. 2). Full details of the impedance chip
shown in Fig. 1 have been described previously.19 Briefly, two
pairs of electrodes are fabricated on the top and bottom of
a micro-channel made from thick resist on glass substrates. The
measured signal is the electrical impedance (real and imaginary)
at suitable applied frequencies (typically two). The signal tran-
sient provides information on cell size, shape, membrane
capacitance, velocity and position in the channel.
A schematic diagram of the microfluidic sample preparation
block is shown in Fig. 2a. The microfluidic block performs
sample (whole blood) loading, pre-treatment and dilution into
two separate fluid channels followed by two separate impedance
chips that are bonded to the block. The bottom arm (containing
ports 1 and 2) takes part of a single blood sample and performs
analysis of WBC differential and Hb concentration. The upper
arm (containing port 3) performs RBC and platelet (PLT) count.
The microfluidic system was designed under the assumption of
low Reynolds numbers which simplifies the design and allows the
microfluidic system to be modelled as a resistive network with
flow rate equivalent to current and pressure equivalent to
potential. The simulation was performed using a PSpice-based
simulator. Fig. 2b shows a CAD layout of the final microfluidic
circuit that is used to process the blood, with separate WBC and
RBC/PLT analysis areas. The microfluidic channels are 200 mm
 100 mm and the flows are controlled by varying the length
(resistance) of the different sections. The two optical windows are
used for Hb measurement, determined using light absorbance.
The various inputs are connected to syringe pumps of different
volume driven by a common mechanism. In future these syringe
pumps will be integrated into a single disposable cartridge. A
photograph of the final device is shown in Fig. 2c.2.1 WBC channel
For WBC analysis, the erythrocytes are lysed in continuous flow
using a mixture of detergent and formic acid.19,23 The lysisThis journal is ª The Royal Society of Chemistry 2011
Fig. 2 (a) Diagram of the WBC/RBC chip processes incorporating lysis
and quench of the blood, followed by WBC count (with optical windows
for haemoglobin). Dilution of the blood for RBC/PLT analysis is shown
in the upper arm. (b) CAD drawing of the microfluidic block showing the
different length channels, the input ports and the two impedance chips.
(c) Photograph of the final microfluidic device made in PMMA.
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View Onlinereagent is delivered by a syringe pump to port 1 where it mixes
with the blood sample that is pumped using a second syringe
pump at a constant flow rate. The initial width of the blood
stream (in the 200 mm wide channel) is 13 mm and diffusion of the
lysis reagent into the blood stream happens quickly (<1 s). The
distance between ports 1 and 2 in Fig. 2a provides 6 seconds
exposure of sample to lysis reagent. The lysis chemistry is
quenched using a second reagent delivered to port 2. The second
longer channel (following port 2) mixes the quench solution with
the lysate, neutralising and stabilising the chemistry. This
produces a clean substantially debris-free sample, containing
leukocytes, which are subsequently analysed by the impedance
chip.2.2 RBC/platelet (PLT) channel
For RBC and PLT analysis, a small amount of the same blood
sample is pumped through the top arm of the device (Fig. 2a),
where it is mixed with a diluent that is pumped into port 3 at four
separate locations. At each point the sample is serially diluted, to
give a 10 000-fold total dilution. At each stage, the blood and
diluent passes through a long mixing channel before being
separated into two; the largest volume is sent to waste, the
smaller to the next dilution stage. The channel lengths are
designed to allow sufficient mixing time, to balance the flow rates
of the different fluids and to match the impedance of the RBC
line to that of the WBC line.Fig. 3 Simulations of flow profiles in microfluidic junction of different
designs at Re ¼ 2.2. (a) Single T junction. (b) Separated double junction.
(c) Optimally spaced double junction. (d) Siphon ratio as function of
Reynolds number for the different designs.2.3 Junction design
For the successful design and stable operation of the microfluidic
sample preparation it is important that the behaviour of the
system is linear over the flow rates of interest. The Reynolds
number (Re) is the ratio of the size of the inertial force to the
viscous forces on a fluid element:This journal is ª The Royal Society of Chemistry 2011Re ¼ r
h
uDh ¼ r
h
ud (1)
where r fluid density, u the average velocity of the fluid, h is the
viscosity of the fluid and Dh the hydraulic diameter of the
channel, which for a square channel is its width d. Recasting this
in terms of flow rate Q ¼ ud2 gives
Re ¼ r
h
ud2
d
¼ r
h
Q
d
(2)
This equation shows that for a required flow rate, a smaller
channel (d) requires a larger pressure but leads to an increase in
the Reynolds number. Typical values for our system are Q ¼ 40
mL min1, r ¼ 103 kg m3, h ¼ 103 Pa$s and d ¼ 300 mm, giving
Re ¼ 2.22.
This moderate Reynolds number indicates that the inertial
forces are strong and care needs to be taken in the design of the
microfluidic sample preparation to ensure linear and stable
operation. In particular the behaviour of the microfluidic junc-
tions should be independent of flow rate up to moderate
Reynolds number. To validate this, the behaviour of the junc-
tions was modelled for different Reynolds number. RBC
measurement requires sequential dilution of the sample, typically
performed using a T-shaped junction shown in Fig. 3a. The
sample is first divided, and most of the material goes to waste,
and a fraction (in the case of these simulations and one junction
in the device, a fraction of 0.1) passes to the second junction
where it is mixed with the diluent. The behaviour of this
junction was simulated for a wide range of Reynolds number and
the siphon ratio, defined as the fraction of the sample passing the
first junction to be diluted, was calculated and is shown in
Fig. 3d. The flow was simulated using FlexPDE (TM, PDE
Solutions, US) for the channel sizes used in the physical device:
300 mm for the sample channel and 200 mm for the waste and
diluent channels. The junctions were located in a long simulation
domain with straight channels and the flow rates were modifiedLab Chip, 2011, 11, 1249–1255 | 1251
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View Onlineby controlling pressure over a wide range applied to inputs and
outputs.
As can be seen from the figure, the siphon ratio depends
strongly on flow rate (Reynolds number) with linear flow and
fixed ratio up to a Reynolds number of approximately 0.2 and an
increasing ratio for higher flow rates. This simple design causes
large errors in dilution at the minimum flow rates required by our
application as indicated by the vertical grey line in Fig. 3d.
Optimisation of channel angles to accommodate the inertial
forces at the first and second junction, as illustrated in Fig. 3b,
stabilises the flow to an extent. Decreasing the separation
distance between the junctions as shown in Fig. 3c further
improves the potential range of operation. The behaviour is
dependent on the balance of mass flows, i.e. that the waste flow
rate and the diluent flow rate are the same.
If these are different, then the range of linear behaviour
decreases. This implies that when the Reynolds number is high,
the inertial effects can be mitigated by designing the junctions in
such a way that the inertias of the different flows balance each
other, demonstrated by the improved operation when the two
junctions are brought together. This junction design (or similar)
guarantees that the simulation of the entire microfluidic system is
linear and can be modelled using equivalent circuit analysis.Fig. 4 (a) Time trace of the unprocessed data captured by the impedance
system. The voltage signal is the magnitude of the impedance measured at
a single frequency. (b) Voltage from a single red blood cell (RBC) (70
mm3) event. The raw data and fitted data are shown. (c) Similar signal for
a small (1 mm3) platelet, with the raw data and fitted model.2.4 Signal analysis and processing
The largest cells in whole blood are monocytes, with typical
diameters in the region of 20 mm (4000 fL). Because it is
important to avoid clogging in the device, the channel width and
height in the impedance analysis chips were set to 40 mm (see
Fig. 1). This implies a sensing volume of 64 000 fL. Although this
is 3 to 5 times less than the sensing volume of a comparable
Coulter aperture, the measurement of small objects like platelets
remains challenging. Mean platelet volumes are typically 6 fL
and a reliable count requires a detection limit of 1 fL, i.e.
a measurement of approximately 0.002% volume fraction.
Fast diagnosis requires fast sample processing and analysis. To
a first approximation a 2 mL blood sample should be measured in
approximately 1 minute. Therefore, the velocity of the fastest
cells (midstream in the flow) is 1 m s1, implying a minimum
event of0.1 ms (for the electrode gap used in these devices). The
bandwidth of the detection electronics must be sufficiently wide
to detect these fast moving events without distortion. The overall
noise level in the electronics is determined by the thermal noise in
the channel impedance and the current-to-voltage converter
feedback resistors, which sets a fundamental limit. Thermal noise
increases as the square root of the system bandwidth, therefore
the noise level increases by a factor of 2 when the cell speed is
increased by a factor of 4. The signal level remains constant so
the signal-to-noise ratio deteriorates by a factor of 2. In order to
run at such high speeds, custom lock-in amplifiers were designed
with optimised 5-pole band pass Bessel filters. The Bessel char-
acteristic preserves the pulse shape without undue distortion, and
the band pass was chosen to allow up to the 5th harmonic
component of the fastest events to pass. With a maximum cell
speed of 1 m s1, and with the 70 mm centre-to-centre distance
of the electrodes, this gives a maximum fundamental frequency
of the cell events in the region of 7 kHz, and a 5th harmonic of
35 kHz.1252 | Lab Chip, 2011, 11, 1249–1255Fig. 4 shows typical data captured by the system. Fig. 4a
illustrates a 20 ms time frame for a sample of diluted whole
blood. The trace shows a small particle followed by 5 larger
particles. Note that dilution of the sample ensures that most
particles arrive separately at random intervals, and overlapping
events are relatively rare (<5%). Individual events are recovered
from the data by matching it against a model function24 of a pair
of anti-symmetric Gaussian peaks. This is illustrated in Fig. 4b,
which provides a close up of a red blood cell (RBC) (70 fL)
event and the model function. In this the correlation coefficient
between the data and model function is >98%. Fig. 4c shows the
data and fit for a small (1 fL) platelet event. This illustrates that
the use of a model function can reliably extract events even when
they are comparable to the thermal noise level.24 TheThis journal is ª The Royal Society of Chemistry 2011
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View Onlineexperimental relationship between impedance measurements and
cell volume was made through reference experiments with
beads.19 For particles which are small (<500 fL) compared to the
measurement volume (64 000 fL), the volume scale is approxi-
mately linear, while for larger particles it is sub-linear.18,22 For
this particular system, the signal is 7 mV fL1 for particles the
size of red blood cells or smaller.3 Experimental
The impedance chips were fabricated from pairs of glass
substrates bonded using adhesive bonding methods. The channel
walls are fabricated from SU-8 and the Pt electrodes manufac-
tured using conventional evaporation and photolithography
techniques. The microfluidic cartridges are micro-milled in
PMMA (Carville, UK). Whole venous blood was collected into
EDTA coated vacutainers from donors participating in the
Philips Research UK donation programme. Lysis solution was
0.12% v/v formic acid, 0.05% w/v saponin; quench solution was
0.6% w/v sodium carbonate, 3% w/v sodium chloride. The RBC
diluent was pocH-pack D diluent (Sysmex, Japan). Blood was
obtained from Addenbrooke’s Hospital pathology laboratory
and University College London Hospital and accompanied by
reference data. Further experimental details can be found else-
where.194 Results
4.1 Microfluidic lysis WBC
An example of a WBC differential is given in Fig. 5a, which
shows an impedance scatter plot for lysed whole blood, where the
lysis was performed in bulk.19 The x-axis is the impedance
magnitude measured at 500 kHz, which is a measure of the
‘‘electrical’’ volume of the cells (F). The y-axis is the ratio of
impedance magnitude measured at 1.7 MHz to 0.5 MHz, termed
the opacity (O). This parameter measures membrane properties
(capacitance) normalised for cell size. The three main sub-Fig. 5 Impedance scatter plots for WBC after lysis colour coded
according to the number of cells. The scatter plot shows cell membrane
opacity (O)—the ratio of impedance measured at 1.7 MHz to 0.5 MHz
plotted against the (electrical) cell volume (F), measured by the imped-
ance magnitude at 500 kHz. (a) Data for whole blood, lysed in bulk. (b)
Data for whole blood lysed using the microfluidic network of Fig. 2.
Ellipsoids are fits determined from. The fitted populations of the 2D
Gaussian are illustrated by the three ovals. The green lines mark positions
of equal probability deviation between the different populations. They
provide the gating boundaries to obtain an accurate count for lympho-
cytes, granulocytes and monocytes.
This journal is ª The Royal Society of Chemistry 2011populations (lymphocytes, monocytes and neutrophils) are
clearly visible (density plot is colour coded). The events at the top
left are RBC ghosts and other debris that is not completely
eliminated by the lysis. Fig. 5b shows data for the same sample
lysed using the microfluidic system. The data are very similar to
the bulk lysis sample, except that the ghost/debris content is
higher.
In the opacity/volume diagram the experimental results of all
cells are summarised by a distribution function N(F,O). We
assume that this distribution function is made up of the sum of
individual cell events of different types (lymphocytes, monocytes
and neutrophils) which are distributed normally around certain
means. For example, for the lymphocytes
PLðF;OÞ¼ 1
2ps1s2
exp
"

ðF FLÞcos qþ ðOOLÞsin q2
2s21

ðOOLÞ cos qþ ðF FLÞsin q2
2s22
#
(3)
where FL and OL are mean lymphocyte volume and opacity, and
s1, s2, q are parameters that describe the spread and orientation
of the ellipsoidal multi-variate distribution. Similar expression
can be written for PG (F,O) and PM (F,O), the granulocyte and
monocyte populations respectively. In Fig. 5, the fitted pop-
ulations of the 2D Gaussian are illustrated by the three ovals.
The correlation coefficient for this fit and the original data is 97%
for Fig. 5a and 96% for Fig. 5b, indicating that the Gaussian
distributions provide a good description of the measured data.
The green lines in Fig. 5 mark positions of equal probability
deviation between the different populations. They provide the
gating boundaries to obtain an accurate count for lymphocytes,
granulocytes and monocytes. The process of 2D Gaussian fitting,
gating and counting is fully automated.
Table 1 shows the cell counts obtained in this way as relative
cell populations for both the bulk lysis experiments of Fig. 5a and
microfluidic lysis experiments of Fig. 5b. The cell counts
obtained for the same sample, measured in the hospital lab
(Addenbrooke’s Hospital, Cambridge, UK), are also shown. As
can been seen, good agreement exists between the different
results. Previously we demonstrated good concordance between
MIC measurements and hospital data for a range of blood
samples measured with bulk lysis.19 Similar concordance is seen
for the microfluidic lysis, with correlation factors of >97%.4.2 RBC/PLT
Counting of RBCs and PLTs was performed using a single
frequency (500 kHz). The cells are easily differentiated by size,Table 1 Relative white blood cell counts for the results in Fig. 5
Lymphocytes
(%)
Monocytes
(%)
Granulocytes
(%)
Hospital 32 7 61
Bulk lysis + MIC 34 8 58
Microfluidic lysis +
MIC
27 8 65
Lab Chip, 2011, 11, 1249–1255 | 1253
Fig. 7 Platelet data from clinically sourced, diluted human whole blood
samples, showing excellent linearity between the absolute platelet counts
obtained from the impedance cytometry system and the hospital central
lab haematology analyzer.
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View Onlinesimplifying the analysis. A representative dataset for a 1 : 10 000
diluted blood sample is shown in Fig. 6. Fig. 6a shows
a frequency histogram of events plotted on a logarithmic scale.
The RBC population is approximately 100 times greater than the
PLT, and the scales are adjusted accordingly. Both the RBC and
PLT size distribution have a characteristic log-normal distribu-
tion. The peak in the platelet distribution corresponds to the
mean human platelet volume25 of 6 fL. In absolute numbers there
are 2570 RBCs per nL and 147 platelets per nL. Fig. 6b shows an
intensity plot of events, where the velocity of the particles
(impedance transient time) is plotted against log10(F). The RBC
intensity distribution shows a peak near 0.8 m s1, with
a maximum velocity near 1.1 m s1. At these high flow rates, the
RBCs are likely to focus into a preferential position in the
channel,16 which results in the distribution shown in the figure.
There is no evidence that the platelet intensity distribution is
other than random, indicating that these much smaller particles
do not focus (the lift forces are too small). Fig. 6b shows better
separation between platelets and RBCs than is evident from
Fig. 6a. The aggregate frequency histogram for both platelets
and RBCs at different velocities is shown in Fig. 6c. Fig. 6d
shows an intensity plot of the correlation coefficient, or goodness
of fit, of each event against the model function of anti-symmetric
Gaussian peaks.24Fig. 6 Red blood cell and platelet data. (a) Event size histogram for
RBC and PLT. There are approximately 100 times fewer platelets events
than RBCs and the frequency axis is scaled by 100. (b) Intensity plot of
individual events plotted as function of size and velocity. (c) Velocity
histogram. (d) Intensity plot of individual events plotted as function
correlation coefficient and size. The limit of detection (LOD) is indicated
by the arrow (left-hand side of figure).
1254 | Lab Chip, 2011, 11, 1249–1255The intensity colour scale is the same as in Fig. 6b, and the vast
majority of individual events are fitted with a correlation coef-
ficient of better than 98%. The tail with lower correlation coef-
ficients of RBC sized events is due to cells that have some overlap
with other cells in the measurement volume. The roll-off in
correlation on the left hand side is signals from very small events
that approach the signal noise floor. The vertical arrow in Fig. 6d
indicates the limit of detection (LOD) of the current system at
70% correlation coefficient. The LOD is approximately an order
of magnitude below the mean platelet volume, giving a value of
approximately 0.6 fL or 1 mm diameter. This LOD means that
the platelets are sized accurately over the entire distribution. The
deviation from the expected log-normal distribution may be due
to cellular debris,26 or may indicate that the system can identify
other smaller objects such as micro-particles.274.3 Platelet concordance
Concordance between PLT counts, especially for very low
platelet numbers is an important challenge for a haematology
PoC test. Data for clinical whole blood samples are shown in
Fig. 7. Comparison of absolute platelet counts with a standard
haematology analyzer revealed excellent linearity with R2 ¼
99.8%, and an offset of 4 platelets nL1. Blank control runs
showed a background count of (2.9  0.3) platelets per nL. The
small offset indicates that the diluent was largely free of platelet-
sized debris, and that the ability to discriminate platelets from
noise is good. However, the fit revealed under-counting of the
platelets by 12% relative to the reference method. A similar
undercounting was also observed for the RBCs. The contributing
main cause of this systematic error is coincident events over the
impedance electrodes that cannot be separated. Straightforward
stochastic reasoning indicates that this effect accounts for 3–5%
undercounting. As the correlation coefficient is so high, we
speculate that the remaining undercounting is due to a systematic
error in the dilution process.5 Conclusions and outlook
Identifying and counting the different subpopulations of human
blood cells are both clinically useful and technologicallyThis journal is ª The Royal Society of Chemistry 2011
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View Onlinechallenging. It provides a useful example application for the
creation of a generic microfluidic platform technology in a single,
hybrid cartridge. The principal demand is to combine sample
preparation with impedance cytometry to cover the large dynamic
range in cell number, size and morphology. In particular, the
ability to count both the relatively abundant, but small platelets at
the same time as counting the relatively rare, but large monocytes,
is a challenge. The technologies require good control of chemistry,
accurate timing and control of flow, and precise control of
concentrations, all of which are delivered through a well designed
microfluidic sample preparation. The system described in this
paper performed cell analysis and enumeration coupled with
sample pre-processing and dilution. Using human blood samples
from clinical sources, it has demonstrated good concordance with
large scale hospital analysers. Beyond PoC blood cell counting,
the microfluidic platform technology will be useful in a range of
applications in the future, including subtyping of blood cells,
counting rare cells, cell assays and other matrices.
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